07-Feb-2007 - US-based nanotech process provider MFIC has announced a 35 per cent increase in revenue over the full-year 2006 to $15.7m (€12.1m), driven by a rising demand from drugmakers for microfluidics products.
07-Feb-2007 - Cardinal Health has reached an agreement with the US Food and Drug Administration (FDA) on plans to resume manufacture and sale of its Alaris (SE) line of infusion pumps. Units were seized and production halted following grave safety concerns surrounding the product back in 2006.
07-Feb-2007 - Laureate Pharma will now offer extra bioprocessing services to its customers following a new partnership deal signed with Boehringer Ingelheim.
06-Feb-2007 - MDS pharma has ceased operations at its bioanalytical services facility in Blainville, Quebec in a bid to boost profitability after an ongoing investigation of the site by the US Food and Drug Administration (FDA).
06-Feb-2007 - Private pharmaceutical firm Tolmar has sold off its pharmaceutical manufacturing plant in a move to fund the purchase of the US assets of biopharmaceutical QLT. The plant, sold for $13.6m (€10.5m), will be leased back to Tolmar under a long-term triple net lease.
05-Feb-2007 - US-based biopharmaceutical product providers Millipore has met its revenue and earnings target over the fiscal year, helped by its Serologicals acquisition in the fourth quarter and a solid performance by its main business driver: lab waters.
05-Feb-2007 - A UK-based firm is offering advice to chemical and pharmaceutical companies on reducing hazardous waste and adhering to the Registration, Evaluation and Authorisation of Chemicals Regulation (REACH), which becomes law on 1 June 2007.
02-Feb-2007 - The first next generation sequencer from Roche and 454 is already proving popular only weeks after its release.
02-Feb-2007 - A new 'lab-on-a-chip' electrophoresis separation device allows higher resolution separations and could enable faster diabetes immunoassay diagnoses.
01-Feb-2007 - Sartorius has reported 7.6 per cent increase in sales revenue in 2006 rising to €520.1m ($677.4m), due to the biotechnology division's decision to focus on disposable systems.
01-Feb-2007 - US-based sterilisation system providers Steris this week announced their fiscal 2007 third quarter results, revealing the impact of the relocation of manufacturing capacity to Mexico and the firm's European restructuring.
31-Jan-2007 - Hospira, Laureate Pharma, QSV Biologics and Cook Pharmacia all bagged new contract manufacturing deals this week.
31-Jan-2007 - Software provider Pharsight has launched an add-on for its graphical drug modelling method to serve in bioequivalence testing, promising to reduce test failure.
30-Jan-2007 - Viral vector manufacturer Lentigen has entered into a collaboration with Wave Biotech to gain access to disposable process and equipment expertise, which ties in with a shift in the bioprocess manufacturing sector towards using disposable systems.
30-Jan-2007 - US-based firm Xcellerex yesterday announced it has completed the second half of a $20m (€15.4m) financing deal, raising $11m to speed up commercialisation of its innovative disposable manufacturing technology for vaccines and biotherapeutics.
29-Jan-2007 - UK based researchers have added another dimension to anti-counterfeiting with an alternative Raman imaging method that is powerful enough to detect fake drugs without opening the package.
26-Jan-2007 - Increased research and development (R&D) spending masks strong revenue growth by PerkinElmer's life and analytical sciences division.
26-Jan-2007 - Waters posted an 11 per cent yearly sales increase on the back of increasing demand from the pharmaceutical industry, generic houses and outsourcing laboratories.
24-Jan-2007 - In a turbulent year, Whatman has failed to meet its projected revenue target by 1-3 per cent and changed its management but resolved litigation that has been hanging over the firm since 2003.
22-Jan-2007 - Agilent Technologies has signed an agreement with Groton Biosystems to co-market measuring solutions for the pharmaceutical industry, as the Process Analytical Technology (PAT) initiative gains popularity among drug manufacturers constantly looking for ways to improve processing efficiencies and costs.
19-Jan-2007 - Oxford Gene Technology and Agilent are to collaborate to develop a global centre of microarray excellence focused on new and emerging applications.
19-Jan-2007 - Agilent, Illumina, NimbleGen and Oxford Gene Technology have stepped into the breach caused by GE Healthcare's decision to scrap its CodeLink arrays.
18-Jan-2007 - US-based Blue Mountain has launched an integrated, comprehensive software package to help life sciences companies manage their assets, cutting out the need for individual software.
17-Jan-2007 - The US Food and Drug Administration has accepted two Celsis drug master files (DMFs) that could increase the adoption of its rapid microbiological detection technology among pharmaceutical manufacturers.
16-Jan-2007 - Russian researchers have developed a new way of sourcing a widely used cardiovascular drug using an ecologically friendly and water-based extraction method, which could yield three-fold cost savings over conventional approaches.